| Study | Simple size | Age | Intervention | Therapy duration | Outcomes | I | C | I | C |
| Li et al. [20] | 35/35 | 68.94 ± 5.66 | 69.67 ± 5.52 | AA + CT | CT | 3∼5 t/d, 3 d | VAS, HHS, AAS | Xu and Li [21] | 38/38 | 66.80 ± 3.73 | 66.88 ± 3.79 | AA + CT | CT | 3∼5 t/d, 2 d | VAS, AAS | Sun [22] | 48/48 | N/A | N/A | AA + CT | CT | 3∼5 t/d, 3 d | ER | Wu and Wang [23] | 35/33 | 39.5 ± 7.1 | 41.3 ± 7.2 | AA + CT | CT | 4∼6 t/d, 3 d | VAS, AAS, AE | Wang et al. [24] | 40/40 | N/A | N/A | AA + CT | CT | 3∼5 t/d | HHS, AE | Yang [25] | 60/60 | 54.6 ± 8.1 | 53.4 ± 8.3 | AA + CT | CT | 3∼4 t/d | VAS, ER | Chen [26] | 30/30 | 73.56 ± 7.09 | 73.48 ± 6.82 | AA + CT | CT | 4 t/d | VAS | Lv [27] | 49/49 | 59.8 ± 8.6 | 59.5 ± 8.7 | AA + CT | CT | 3∼5 t/d, 3 d | VAS | Zhu [28] | 235/183 | 59.84 ± 6.13 | 60.19 ± 5.74 | AA + CT | CT | 4 t/d | VAS, HHS, AAS, AE | Shen and Zhou [29] | 40/40 | N/A | N/A | AA + CT | CT | 3∼5 t/d, 3 d | VAS, HHS | Tian et al. [30] | 36/36 | N/A | N/A | AA + CT | CT | 3∼5 t/d, 3 d | VAS | Xu [31] | 19/19 | 60.74 ± 8.76 | 59.32 ± 7.68 | AA + CT | CT | 3∼5 t/d, 3 d | VAS, AE | Wang et al. [32] | 30/30 | 60.93 ± 5.90 | 59.87 ± 6.21 | AA + CT | CT | 4 t/d | VAS, HHS, AAS, AE | Usichenko et al. [33] | 29/25 | 68 ± 10 | 66 ± 11 | AA + CT | CT | 3 d | VAS, AAS, AE |
|
|